Xalkori (crizotinib) – Vision disorders and need for monitoring in paediatric patients
03/11/2022
Medicines for human use
Direct healthcare professional communication (DHPC)
Xalkori (crizotinib): Vision disorders, including risk of severe vision loss, need for monitoring in paediatric patients